Annual Operating Profit
-$4.79 M
+$3.89 M+44.83%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual operating income is -$4.79 million, with the most recent change of +$3.89 million (+44.83%) on December 31, 2023.
- During the last 3 years, SBFM annual operating profit has fallen by -$4.21 million (-729.49%).
- SBFM annual operating profit is now -36429.01% below its all-time high of -$13.10 thousand, reached on July 1, 2007.
Performance
SBFM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.11 M
+$161.90 K+12.77%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly operating income is -$1.11 million, with the most recent change of +$161.90 thousand (+12.77%) on September 30, 2024.
- Over the past year, SBFM quarterly operating profit has dropped by -$326.90 thousand (-41.94%).
- SBFM quarterly operating profit is now -48004.35% below its all-time high of -$2300.00, reached on January 1, 2008.
Performance
SBFM Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$4.91 M
-$326.90 K-7.13%
September 30, 2024
Summary
- As of February 7, 2025, SBFM TTM operating income is -$4.91 million, with the most recent change of -$326.90 thousand (-7.13%) on September 30, 2024.
- Over the past year, SBFM TTM operating profit has increased by +$3.75 million (+43.27%).
- SBFM TTM operating profit is now -55723.86% below its all-time high of -$8800.00, reached on October 1, 2007.
Performance
SBFM TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
SBFM Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.8% | -41.9% | +43.3% |
| 3 y3 years | -729.5% | -9.1% | +48.8% |
| 5 y5 years | -311.0% | -9.1% | +48.8% |
SBFM Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -96.1% | +44.8% | -295.7% | +78.0% | -105.7% | +48.8% |
| 5 y | 5-year | -729.5% | +44.8% | -2834.8% | +78.0% | -914.6% | +48.8% |
| alltime | all time | <-9999.0% | +44.8% | <-9999.0% | +78.0% | <-9999.0% | +48.8% |
Sunshine Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.11 M(-12.8%) | -$4.91 M(+7.1%) |
| Jun 2024 | - | -$1.27 M(-6.1%) | -$4.59 M(+5.9%) |
| Mar 2024 | - | -$1.35 M(+13.8%) | -$4.33 M(-9.9%) |
| Dec 2023 | -$4.79 M(-44.8%) | -$1.19 M(+52.3%) | -$4.81 M(-44.5%) |
| Sep 2023 | - | -$779.50 K(-23.1%) | -$8.66 M(-9.8%) |
| Jun 2023 | - | -$1.01 M(-44.6%) | -$9.60 M(+3.4%) |
| Mar 2023 | - | -$1.83 M(-63.7%) | -$9.28 M(+7.0%) |
| Dec 2022 | -$8.67 M(+255.5%) | -$5.04 M(+193.2%) | -$8.67 M(+121.5%) |
| Sep 2022 | - | -$1.72 M(+146.9%) | -$3.92 M(+45.3%) |
| Jun 2022 | - | -$695.80 K(-43.1%) | -$2.70 M(+12.9%) |
| Mar 2022 | - | -$1.22 M(+337.6%) | -$2.39 M(-2.1%) |
| Dec 2021 | -$2.44 M(+323.0%) | - | - |
| Dec 2021 | - | -$279.60 K(-43.7%) | -$2.44 M(-2.5%) |
| Sep 2021 | - | -$496.30 K(+27.7%) | -$2.50 M(+20.7%) |
| Jun 2021 | - | -$388.60 K(-69.5%) | -$2.07 M(+14.3%) |
| Mar 2021 | - | -$1.28 M(+271.6%) | -$1.81 M(+214.6%) |
| Dec 2020 | -$576.90 K(-10.1%) | -$343.30 K(+410.1%) | -$576.90 K(+19.1%) |
| Sep 2020 | - | -$67.30 K(-47.7%) | -$484.20 K(-21.8%) |
| Jun 2020 | - | -$128.60 K(+241.1%) | -$619.50 K(+11.2%) |
| Mar 2020 | - | -$37.70 K(-85.0%) | -$557.10 K(-13.2%) |
| Dec 2019 | -$641.60 K(-44.9%) | -$250.60 K(+23.7%) | -$641.60 K(+20.0%) |
| Sep 2019 | - | -$202.60 K(+206.0%) | -$534.70 K(-13.9%) |
| Jun 2019 | - | -$66.20 K(-45.8%) | -$620.90 K(-45.3%) |
| Mar 2019 | - | -$122.20 K(-15.0%) | -$1.14 M(-3.8%) |
| Dec 2018 | -$1.16 M(+35.8%) | -$143.70 K(-50.2%) | -$1.18 M(-1.5%) |
| Sep 2018 | - | -$288.80 K(-50.2%) | -$1.20 M(+17.1%) |
| Jun 2018 | - | -$580.50 K(+248.2%) | -$1.02 M(+11.8%) |
| Mar 2018 | - | -$166.70 K(+2.8%) | -$914.90 K(+6.7%) |
| Dec 2017 | -$857.20 K(-13.7%) | -$162.20 K(+42.5%) | -$857.20 K(-16.9%) |
| Sep 2017 | - | -$113.80 K(-75.9%) | -$1.03 M(-0.2%) |
| Jun 2017 | - | -$472.20 K(+333.2%) | -$1.03 M(+0.1%) |
| Mar 2017 | - | -$109.00 K(-67.6%) | -$1.03 M(+4.0%) |
| Dec 2016 | -$993.10 K | -$336.10 K(+189.7%) | -$993.10 K(+19.5%) |
| Sep 2016 | - | -$116.00 K(-75.4%) | -$831.20 K(+0.4%) |
| Jun 2016 | - | -$471.30 K(+576.2%) | -$828.30 K(+14.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$69.70 K(-60.0%) | -$725.20 K(-7.1%) |
| Dec 2015 | -$780.30 K(-55.5%) | -$174.20 K(+54.0%) | -$780.30 K(-14.5%) |
| Sep 2015 | - | -$113.10 K(-69.3%) | -$912.40 K(-15.3%) |
| Jun 2015 | - | -$368.20 K(+195.0%) | -$1.08 M(-27.0%) |
| Mar 2015 | - | -$124.80 K(-59.3%) | -$1.47 M(-16.0%) |
| Dec 2014 | -$1.76 M(-9.3%) | -$306.30 K(+10.4%) | -$1.76 M(-17.8%) |
| Sep 2014 | - | -$277.40 K(-63.8%) | -$2.13 M(+4.9%) |
| Jun 2014 | - | -$765.50 K(+88.6%) | -$2.03 M(+43.1%) |
| Mar 2014 | - | -$405.90 K(-40.8%) | -$1.42 M(-26.7%) |
| Dec 2013 | -$1.94 M(+174.0%) | -$685.40 K(+285.7%) | -$1.94 M(+34.5%) |
| Sep 2013 | - | -$177.70 K(+16.4%) | -$1.44 M(-12.1%) |
| Jun 2013 | - | -$152.60 K(-83.5%) | -$1.64 M(+3.1%) |
| Mar 2013 | - | -$922.90 K(+390.1%) | -$1.59 M(+125.0%) |
| Dec 2012 | -$706.70 K(+27.1%) | -$188.30 K(-50.0%) | -$706.70 K(-20.6%) |
| Sep 2012 | - | -$376.40 K(+266.5%) | -$890.50 K(+41.2%) |
| Jun 2012 | - | -$102.70 K(+161.3%) | -$630.50 K(+15.8%) |
| Mar 2012 | - | -$39.30 K(-89.4%) | -$544.30 K(-1.8%) |
| Dec 2011 | -$556.20 K(+3.5%) | -$372.10 K(+219.7%) | -$554.20 K(-9.0%) |
| Sep 2011 | - | -$116.40 K(+605.5%) | -$609.00 K(-6.7%) |
| Jun 2011 | - | -$16.50 K(-66.5%) | -$653.00 K(-70.6%) |
| Mar 2011 | - | -$49.20 K(-88.5%) | -$2.22 M(+0.7%) |
| Dec 2010 | -$537.40 K(+437.4%) | -$426.90 K(+166.1%) | -$2.21 M(+23.9%) |
| Sep 2010 | - | -$160.40 K(-89.9%) | -$1.78 M(+7.8%) |
| Jun 2010 | - | -$1.59 M(+4489.9%) | -$1.65 M(+2204.6%) |
| Mar 2010 | - | -$34.60 K(+8.1%) | -$71.80 K(+66.6%) |
| Dec 2009 | -$100.00 K(+536.9%) | - | - |
| Oct 2009 | - | -$32.00 K(+515.4%) | -$43.10 K(+174.5%) |
| Jul 2009 | -$15.70 K(-39.8%) | -$5200.00(+108.0%) | -$15.70 K(+6.8%) |
| Apr 2009 | - | -$2500.00(-26.5%) | -$14.70 K(-36.1%) |
| Jan 2009 | - | -$3400.00(-26.1%) | -$23.00 K(+5.0%) |
| Oct 2008 | - | -$4600.00(+9.5%) | -$21.90 K(-16.1%) |
| Jul 2008 | -$26.10 K(+99.2%) | -$4200.00(-61.1%) | -$26.10 K(+19.2%) |
| Apr 2008 | - | -$10.80 K(+369.6%) | -$21.90 K(+97.3%) |
| Jan 2008 | - | -$2300.00(-73.9%) | -$11.10 K(+26.1%) |
| Oct 2007 | - | -$8800.00 | -$8800.00 |
| Jul 2007 | -$13.10 K | - | - |
FAQ
- What is Sunshine Biopharma annual operating income?
- What is the all time high annual operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma annual operating profit year-on-year change?
- What is Sunshine Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly operating profit year-on-year change?
- What is Sunshine Biopharma TTM operating income?
- What is the all time high TTM operating profit for Sunshine Biopharma?
- What is Sunshine Biopharma TTM operating profit year-on-year change?
What is Sunshine Biopharma annual operating income?
The current annual operating profit of SBFM is -$4.79 M
What is the all time high annual operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high annual operating income is -$13.10 K
What is Sunshine Biopharma annual operating profit year-on-year change?
Over the past year, SBFM annual operating income has changed by +$3.89 M (+44.83%)
What is Sunshine Biopharma quarterly operating income?
The current quarterly operating profit of SBFM is -$1.11 M
What is the all time high quarterly operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly operating income is -$2300.00
What is Sunshine Biopharma quarterly operating profit year-on-year change?
Over the past year, SBFM quarterly operating income has changed by -$326.90 K (-41.94%)
What is Sunshine Biopharma TTM operating income?
The current TTM operating profit of SBFM is -$4.91 M
What is the all time high TTM operating profit for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM operating income is -$8800.00
What is Sunshine Biopharma TTM operating profit year-on-year change?
Over the past year, SBFM TTM operating income has changed by +$3.75 M (+43.27%)